Latest news with #Benzinga
Yahoo
16 hours ago
- Business
- Yahoo
While Most Redditors Panic-Sell Bitcoin Below $100K, These Investors Are Buying the Blood
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The cryptocurrency market is experiencing its most dramatic selloff in months, with Bitcoin plummeting below the psychologically critical $100,000 level and Ethereum bleeding from $2,700 to $2,100 in just one week. But behind the panic selling and social media despair, a fascinating divide is emerging between seasoned investors and newcomers—one that could determine who survives this downturn. For crypto investors accustomed to market volatility driven by regulatory news or institutional adoption, this geopolitical trigger represents something different: a reminder that digital assets, despite their decentralized nature, remain deeply connected to global risk sentiment. Don't Miss: Trade crypto futures on Plus500 with up to $200 in bonuses — no wallets, just price speculation and free paper trading to practice different strategies. Grow your IRA or 401(k) with Crypto – unlock the power of alternative investments including a Crypto IRA within your retirement account. 'The spike in oil prices will hurt the world,' noted one investor, capturing the broader economic implications that extend far beyond crypto portfolios. What's most revealing isn't the price action itself, but how different types of investors are responding. The cryptocurrency community is essentially splitting into two camps, each with dramatically different strategies. The Panic Sellers are experiencing what one investor called being 'beyond exhausted' and 'sad and tired as a crypto investor.' Comments like 'I am never going to financially recover from this' and admissions of being 'down 55%' reveal the emotional toll of this downturn. Many are questioning fundamental assumptions about crypto cycles, with one noting: 'The biggest mistake I made was thinking that Bitcoin runs up first and then alt season happens like in 2021.' The Opportunistic Buyers, however, are taking a completely different approach. 'Buy when there's blood on the streets,' advised one, while another declared: 'F*ck those who are scared, I'm buying more.' These investors are thanking panic sellers for providing 'retail exit liquidity' and planning to 'DCA down' during the chaos. Trending: New to crypto? Get up to $400 in rewards for successfully completing short educational courses and making your first qualifying trade on Coinbase. Perhaps nowhere is the divide more apparent than in attitudes toward alternative cryptocurrencies. The 'altcoin bloodbath' has been particularly brutal, with one investor observing: 'Total 3 Alts chart is literally going straight down parabolic. Guess this is the alt season they've been talking about. Just the wrong way.' This has led to a notable shift in strategy among experienced investors. 'Gave up on Alts years ago. Stack sats and enjoy the ride,' commented one Bitcoin maximalist, while another admitted selling 'most of these sh*tty alts' before the crash. The harsh reality? Many altcoins that seemed promising during the bull run are now revealing their lack of fundamental value during this stress test. Despite the doom and gloom dominating social media, a closer look at investor behavior reveals three key strategies emerging among those who've survived previous crypto winters: 1. Flight to Bitcoin Quality: Experienced investors are consolidating positions in Bitcoin rather than diversifying across numerous altcoins. The philosophy is simple: if you're going to weather a crypto winter, do it with the most established digital asset. 2. Dollar-Cost Averaging Into Chaos: Rather than trying to time the bottom, methodical investors are using systematic buying during the decline. As one put it: 'DCA down today and Monday.' 3. Emotional Detachment: The most successful crypto investors have learned to separate their emotions from their investment decisions. While newcomers express despair, veterans are making calculated moves based on long-term conviction rather than short-term isn't crypto's first rodeo with geopolitical chaos. Digital assets have weathered the COVID pandemic, Russia's invasion of Ukraine, banking sector stress, and multiple regulatory crackdowns. Each time, the same pattern emerges: panic selling creates opportunities for patient capital. What's different this time is the scale of institutional involvement. Unlike previous crypto winters, major corporations, ETFs, and sovereign wealth funds now hold significant Bitcoin positions. This institutional backing provides a different foundation than purely retail-driven markets of the past. Scenario 1: Extended Winter – If geopolitical tensions escalate further, crypto could face months of suppressed prices as risk assets broadly decline. Bitcoin could test lower support levels, potentially reaching the $80,000-$90,000 range that some analysts are predicting. Scenario 2: Quick Recovery – Should tensions de-escalate quickly, crypto's oversold condition could lead to a sharp rebound, similar to previous geopolitical scares that proved temporary. Scenario 3: Selective Survival – The most likely outcome may be a market that separates winners from losers more definitively, with Bitcoin and a handful of altcoins with real utility surviving while weaker projects fade away. This crypto crash is serving as a brutal but necessary stress test. It's separating investors who understand the long-term potential of digital assets from those who were simply riding momentum. For those with strong stomachs and long-term conviction, this period may represent the kind of opportunity that creates 'generational wealth'—though only for investors who can withstand the emotional and financial pressure of watching their portfolios decline in the short term. The key question isn't whether Bitcoin will recover from below $100,000—history suggests it will. The question is whether individual investors have the patience, risk tolerance, and strategic thinking to benefit when it does. As one investor philosophically noted: 'If you're a man, you don't cry about it, you take life, the ups and downs; if you're a real man you never go down, you just stay up!' The crypto market is delivering its harshest lesson yet. Those who learn from it may find themselves significantly wealthier on the other side. Read Next: Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can invest with $1,000 at just $0.30/share. This article While Most Redditors Panic-Sell Bitcoin Below $100K, These Investors Are Buying the Blood originally appeared on
Yahoo
a day ago
- Business
- Yahoo
Bitcoin's Cooling Off—Why These 5 'Underdog' Cryptos Are Stealing the Spotlight This Week
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. What It Is: Jito, or JTO, is a decentralised liquid staking protocol built on Solana, offering users yield-optimised staking with MEV rewards. Think of it as the sophisticated cousin of traditional staking—you earn rewards not just from validating transactions, but also from Maximum Extractable Value opportunities. Why It Matters: Jito's open-source approach combines MEV infrastructure and liquid staking to enhance Solana's efficiency, reduce network congestion, and provide additional rewards for validators, searchers, and stakers. In practical terms, this means Solana users can stake their SOL tokens while maintaining liquidity through JitoSOL, earning both staking rewards and MEV profits. Don't Miss: Trade crypto futures on Plus500 with up to $200 in bonuses — no wallets, just price speculation and free paper trading to practice different strategies. Grow your IRA or 401(k) with Crypto – unlock the power of alternative investments including a Crypto IRA within your retirement account. The Opportunity: With Solana's ecosystem continuing to mature, Jito has positioned itself as essential infrastructure. Forecasts suggest JTO could reach $2.59 by the end of 2025, representing a potential 61% increase from current levels. For context, that's the kind of return traditional investors chase for years, potentially compressed into months. What It Is: The original Bitcoin fork created to solve scalability issues through larger block sizes, allowing for faster and cheaper transactions than Bitcoin itself. Why It's Moving: Recent analysis by BeInCrypto predicts BCH could break above $500 and reach over $550, driven by renewed institutional interest and technical breakout patterns. Bitcoin Cash surges 7% as geopolitical tensions drive investor interest, with BCH searches up 28% and triple wedge breakout. The Bigger Picture: Analysts highlight Ethereum, Solana, and Bitcoin Cash as the best altcoins to buy this month for breakout potential and utility. What's fascinating is BCH's quiet performance—it's gaining without the Twitter hype or celebrity endorsements that drive other tokens. Reality Check: Some predict it could aim for a target of $710 by the end of 2025, though others remain cautious. The key is whether BCH can maintain momentum beyond technical patterns. Trending: New to crypto? Get up to $400 in rewards for successfully completing short educational courses and making your first qualifying trade on Coinbase. What It Is: A purpose-built blockchain designed specifically for trading applications, offering sub-second finality and native order matching. Why It's Hot: Sei represents a different approach to blockchain design—instead of being a general-purpose platform trying to do everything, it's laser-focused on optimizing for trading and DeFi applications. This specialization is paying off as more projects seek infrastructure that can handle high-frequency trading demands. The Technical Edge: With built-in order matching and MEV protection, Sei offers institutional-grade trading infrastructure that traditional exchanges struggle to match. The 15.28% weekly gain reflects growing recognition of this specialized approach. Investment Thesis: As crypto trading volumes continue growing, infrastructure tokens like SEI could see disproportionate benefits. It's picking up the pieces where generalist blockchains fall short. What It Is: A decentralized exchange and liquidity hub built on Base — Coinbase's Layer 2 — designed to be the central trading venue for the Base ecosystem. The Coinbase Factor: Being the primary DEX on Coinbase's blockchain gives AERO significant structural advantages. As Base grows, AERO captures value from increased trading volume and liquidity provision. Performance Story: The 26.06% weekly gain suggests institutional money is taking notice. When Coinbase commits resources to Base's growth, AERO directly benefits from that investment. Strategic Position: While other DEXs compete in crowded markets, AERO has a quasi-monopolistic position on one of crypto's most promising Layer 2 It Is: The token that's quietly outperforming everything else on this list, with nearly 28% gains over seven days and an impressive 13.11% jump in just 24 hours. The Mystery Factor: Sometimes the biggest winners are the ones flying under the radar. Kaia's performance suggests institutional accumulation or major developments that haven't hit mainstream crypto media yet. Risk vs. Reward: The dramatic outperformance could signal either tremendous opportunity or dangerous speculation. The 1.76% hourly gain shows continued momentum, but such rapid moves require careful position sizing. These five tokens represent different investment philosophies: infrastructure plays like Jito and Sei, ecosystem bets like AERO, comeback stories like BCH, and pure momentum like Kaia. What they share is actual utility beyond speculative trading. The broader lesson? While everyone watches Bitcoin's next move, real opportunities often emerge in projects solving specific problems with measurable traction. Whether it's Jito's staking innovation or AERO's Base ecosystem play, these tokens have fundamental reasons for their price action. Read Next: Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can invest with $1,000 at just $0.30/share. This article Bitcoin's Cooling Off—Why These 5 'Underdog' Cryptos Are Stealing the Spotlight This Week originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Business
- Yahoo
First They Bought Entire Neighborhoods – Now Wall Street Is Coming For The Equity In Your Neighbor's Home
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Wall Street's move into single-family housing made national headlines just a few years like Blackstone and Invitation Homes were on a buying spree, snapping up tens of thousands of homes and building large-scale rental portfolios. Entire communities were developed specifically to rent, not own. It was one of the biggest shifts in the U.S. housing market in decades, and it priced out plenty of would-be homeowners in the process. That frenzy has cooled. But the capital hasn't gone far. Now, instead of buying the house, institutional investors are buying the upside. They're targeting the equity inside owner-occupied homes. This new strategy doesn't involve tenants or any property management. Just a stake in future home appreciation. The instrument making this possible is called a Home Equity Agreement (HEA).It gives homeowners a lump sum of cash in exchange for a share of the home's future value when it sells. Unlike a home equity line of credit (HELOC), there's no debt, monthly payment or interest rate. That model has gained traction fast, especially with firms looking for real estate exposure without operational drag. Companies like Barclays, KKR, Nomura, Carlyle Group and others have invested billions of dollars into securitizations backed by HEAs. These securitizations have given large investors a new pipeline into U.S. residential equity. The structure of HEAs is designed to give investors returns that outperform the actual price movement of the home. This is achieved through an equity exchange rate. In simple terms, if the home's value increases by 3% annually, investors can realize annual returns of 15% or more. And while appreciation is the obvious draw, the downside protection is quietly just as important. If home prices fall, the same exchange rate provides a buffer that allows investors to still come out ahead with positive gains. All of this is happening against the backdrop of one of the biggest pools of wealth in the country; $35 trillion in U.S. home equity. Most of it is sitting idle and untapped. It was only a matter of time before institutional investors created a new opportunity out of this market. HEAs weren't structured for individuals, and the funds buying them weren't open to the public. However, that's beginning to change. , a fintech-backed platform, is opening the door through its U.S. Home Equity Fund (HEF). The private fund that allows accredited investors to participate in a diversified portfolio of HEAs. The fund invests in home equity in some of the most stable housing markets across the U.S. and has achieved a 17% IRR on its realized investments since inception. The single-family rental boom may have dominated the past decade, but home equity is next. Wall Street has already moved in. Now, with the right access point, individual investors can follow. Image: Shutterstock This article First They Bought Entire Neighborhoods – Now Wall Street Is Coming For The Equity In Your Neighbor's Home originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.

Associated Press
a day ago
- Health
- Associated Press
EXECUTIVE INTERVIEW: SeaStar CMO And Pediatric Specialist Talk About Promising Therapy To Treat Pediatric AKI
By Meg Flippin, Benzinga DETROIT, MICHIGAN - June 27, 2025 ( NEWMEDIAWIRE ) - Dr. Kevin Chung, Chief Medical Officer at SeaStar Medical Holding Corporation (NASDAQ: ICU) and Dr. Stuart L. Goldstein, MD, from Cincinnati Children's Hospital Medical Center, were recently guests on Benzinga's All-Access. The two were on hand to discuss QUELIMMUNE, SeaStar Medical's humanitarian medical device that was granted U.S. FDA approval to treat pediatric patients with acute kidney injury (AKI) due to sepsis or a septic condition. Dr. Goldstein was the chief investigator for the two studies that led to the FDA approval. Pediatric AKI is a sudden episode of kidney failure that happens within a few hours or days. It can be brought on by several conditions including sepsis, severe trauma and surgery. AKI can cause hyperinflammation, which is the overproduction or overactivity of inflammatory effector cells and other molecules that can be toxic. Damage resulting from hyperinflammation in AKI can progress to other organs, such as the heart or liver and potentially lead to multi-organ dysfunction or even failure that could result in worse outcomes, including increased risk of death. Even after resolution, patients may face complications including chronic kidney disease or end-stage renal disease requiring dialysis. Treating The Untreatable There are about 4,000 cases of pediatric AKI each year in the U.S., Dr. Chung shared, and the mortality rate among those patients is high at 50%. QUELIMMUNE, which was granted approval under a Humanitarian Device Exemption (HDE) by the FDA in February 2024, was developed to treat AKI among children. 'QUELIMMUNE is designed to target the innate immune response. When patients get very sick, it becomes very dysregulated and cells go haywire and trigger something called the cytokine storm,' said Dr. Chung in the interview. 'The QUELIMMUNE device is designed specifically to target the cytokine storm at the source of the storm, and it is associated with really good outcomes, especially in the pediatric population where mortality was cut in half from 50% to 25%.' That reduction in mortality is quite promising given that while there have been medical advances in treating AKI over the years, including targeted medications, nothing has been able to help patients with AKI so severe that it requires dialysis or inflammation so bad that it has increased the chance of death, Dr. Goldstein noted. But QUELIMMUNE proved very effective in trials, surprising even Dr. Goldstein, and that is why it received FDA approval and is being used in hospitals around the country. 'What we saw as we started the initial trial is kids that had a 50% chance of mortality, not only did that go in half, but we saw a dramatic improvement almost in 24 to 48 hours, which was quite shocking to us frankly,' said Dr. Goldstein. What's more, of the patients who survived, they were off dialysis sixty to ninety days later, something unheard of. Typically, 10-30% of pediatric patients who survive an AKI episode require chronic dialysis, Dr. Goldstein shared. 'It's a dramatic improvement that you see almost within the first one to two days. It is nothing I've seen before in clinical medicine in the last quarter century,' he stated further. Looking Beyond Pediatric AKI In addition to treating pediatric AKI, SeaStar is currently engaged in a trial evaluating the safety and efficacy of QUELIMMUNE for treating adult AKI. The study has over 100 patients enrolled, and the company is shooting for a total of 200. Beyond that, Dr. Chung said the idea is to use QUELIMMUNE for any condition in which the innate immune system is disturbed. 'The therapy itself is organ- and disease-agnostic,' said Dr. Chung, noting the company has six Breakthrough Device Designations from the FDA. BDD is designed to encourage speedier development of certain medical devices when there is a reasonable chance of providing a better treatment or diagnosis than the current standard of care. The BDD status is reserved for those diseases that are life-threatening or can cause irreversibly debilitating effects on patients. 'Other disease states are definitely going to be next,' Dr. Chung told Benzinga. Featured image from Shutterstock . This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. This content was originally published on Benzinga. Read further disclosures here.
Yahoo
a day ago
- Business
- Yahoo
Bitcoin, Ethereum, XRP, Dogecoin Hold Gains As Crypto ETF Inflows Continue
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Crypto markets are holding steady, boosted by growing optimism over a potential Federal Reserve rate cut, Arizona's new Bitcoin reserve law, and continued institutional Ticker Price Bitcoin (CRYPTO: BTC) $107,127.27 Ethereum (CRYPTO: ETH) $2,426.90 Solana (CRYPTO: SOL) $145.86 XRP (CRYPTO: XRP) $2.19 Dogecoin (CRYPTO: DOGE) $0.1653 Shiba Inu (CRYPTO: SHIB) $0.00001162 Notable Statistics: IntoTheBlock data shows Bitcoin and Ethereum large transaction volume increasing by 9% and 12%, respectively. Daily active addresses are up by 12% and 19.6%, respectively. Coinglass data shows 76,197 traders were liquidated in the past 24 hours for $169.71 million. SoSoValue data shows net inflows of $588.6 million into spot Bitcoin ETFs on Tuesday, while spot Ethereum ETFs saw net inflows of $71.2 million. Trader Notes: Crypto trader Jelle highlighted Bitcoin's quick recovery after briefly dipping below recent lows. The reclaim of a key resistance level suggests strength, with liquidity clusters just overhead, potentially setting up for a rapid upside move.. Don't Miss: Your Crypto, Locked Down: Store Bitcoin, Ethereum, and more, with the Ledger Nano S Plus — trusted by millions worldwide, and yours for only $79. New to crypto? Get up to $400 in rewards for successfully completing short educational courses and making your first qualifying trade on the other hand, Rekt Capital noted Bitcoin is now positioned to break out of its multi-week downtrend. But to confirm a reversal, Bitcoin must close the week solidly above a key diagonal trendline, not just wick above it. Ted Pillows pointed out that Ethereum is currently holding the range low but must reclaim $2,525 to resume upward momentum toward the range highs. Ameba observed that Solana's reclaim of the MH level could lead to a short-term surge toward the monthly open. A breakout above that would likely bring strong bullish momentum. Trader Tardigrade emphasized that Dogecoin continues to respect a long-term weekly support trendline that's held for over 18 months, suggesting the meme coin remains technically sound. Read Next: Grow your IRA or 401(k) with Crypto – unlock the power of alternative investments including a Crypto IRA within your retirement account. A must-have for all crypto enthusiasts: Sign up for the Gemini Credit Card today and earn rewards on Bitcoin Ether, or 60+ other tokens, with every purchase. Image: Shutterstock This article Bitcoin, Ethereum, XRP, Dogecoin Hold Gains As Crypto ETF Inflows Continue originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati